Grant Waring

OBodies Ltd. engages in the research and development of affinity proteins. It offers antibody-like biopharmaceuticals derived from proteins. The firm's platform technology has applications within clinical diagnostics, point of care diagnostics, biotechnology research, industrial biotechnology, and medical therapeutics. The company was founded in 2007 and is headquartered in Hamilton, New Zealand.

New Zealand Institute of Chartered Accountants operates as an institute of chartered accountants. The company is headquartered in Wellington, New Zealand.

Graftoss Ltd. develops orthopedic devices which have bone graft and bone replacement applications. The firm's bone matrix technology has applications as a xenograft material for human and veterinary grafting, including spinal fusion, hand and foot surgery, simple and complex fractures repair, joint reconstruction and dental implants and as an antibiotic impregnated graft material for application in conditions such as osteomyelitis. The company was founded in 2007 and is headquartered in Hamilton, New Zealand.

Novatein Ltd. develops and manufactures bio-derived polymers and materials for use in plastics, composites, agriculture and horticulture, manufacturing and construction. Its materials include novatein, is a bio-plastic which can be reformulated, modified and optimized to suit a particular products attributes, feather fibre materials and bio-waste polymers. The company was founded in 2007 and is headquartered in Hamilton, New Zealand.